Luminist Capital’s Johnson & Johnson JNJ Stock Holding History

Luminist Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-24	Closed	-$5.01K	–	194
2025 Q4	$5.01K	Buy	24 +11	+85%	+$2.17K	0.01%	180
2025 Q3	$2.44K	Hold	13	–	–	﹤0.01%	267
2025 Q2	$2.03K	Sell	13 -7	-35%	-$1.08K	﹤0.01%	268
2025 Q1	$3.01K	Hold	20	–	–	﹤0.01%	192
2024 Q4	$2.82K	Buy	+20	New	+$3.1K	﹤0.01%	182

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Luminist Capital's JNJ Position: Q1 2026 in Review

Luminist Capital sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 24 shares — an estimated $5.01K sold.

Luminist Capital first reported a position in JNJ in Q4 2024 and held it in 5 quarters. The position peaked at $5.01K in Q4 2025. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Luminist Capital reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
Luminist Capital sold 24 Johnson & Johnson shares in Q1 2026, an estimated $5.01K.
Luminist Capital first reported a position in Johnson & Johnson in Q4 2024 and held it in 5 quarters.
Luminist Capital's Johnson & Johnson position peaked at $5.01K in Q4 2025.
4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Luminist Capital's 13F filing for Q1 2026, filed 24 Apr 2026.